Link Therapeutics Inc.
PrivateLast Round
Series B
Jul 18, 2025
Total Funding Raised
$7.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Link Therapeutics Inc. is a biotechnology company that develops therapeutic methods and medical devices for autoimmune diseases by targeting and removing pathogenic autoantibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Link Therapeutics Inc. Comparables
Compare Link Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Otsuka Holdings | 76% | |
| POCARD Ltd. | 73% | |
| Vitrosorb AB | 72% | |
Link Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 18, 2025 | ||||
| Series A | Feb 28, 2023 | ||||
| Seed | Dec 22, 2022 |
Link Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ITOCHU Technology Ventures | Series B |
| Kobe University Capital | Series B |
| Mitsubishi UFJ Capital | Series B, Series A |
| Kyoto University Innovation Capital | Series B, Series A, Seed |
| SMBC Venture Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 33% MoM, reaching 1.1K.
- Jul 18, 2025
$5.7M round with participation from ITOCHU Technology Ventures and SMBC Venture Capital.
Link Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Link Therapeutics Inc.'s valuation, stock price, and market status.